SMX; Sulfamethylisoxazol; Sulfisomezole; Sulfamethazole
Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic. It is most often used as part of a synergistic combination with trimethoprim in a 5:1 ratio in co-trimoxazole. Its primary activity is against susceptible forms of Streptococcus, Staphylococcus aureus (including MRSA), Escherichia coli, Haemophilus influenzae, and oral anaerobes. It is commonly used to treat urinary tract infections. In addition it can be used as an alternative to amoxicillin-based antibiotics to treat sinusitis. It can also be used to treat toxoplasmosis and it is the drug of choice for Pneumocystis pneumonia, which affects primarily patients with HIV. Sulfonamides are structural analogs and competitive antagonists of para-aminobenzoic acid (PABA). They inhibit normal bacterial utilization of PABA for the synthesis of folic acid, an important metabolite in DNA synthesis.
Organism species: Pan-species (General)
- Customized Service n/a Complete Antigen of Sulfamethoxazole (SMZ) Antigenic Transformation Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Sulfamethoxazole (SMZ) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Sulfamethoxazole (SMZ) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Sulfamethoxazole (SMZ) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Sulfamethoxazole (SMZ) ELISA Kit Customized Service Offer